Browsing by Subject "Tissue and Organ Procurement"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Health Related Philanthropy: The Donation of the Body (And Parts Thereof)
    (2006-09-05T14:59:22Z) Indiana University Center for Bioethics, Health Related Philanthropy Study Group
    The academic study of philanthropy has focused on private action for the public good, and on the area of various determinants of giving. Yet one very obvious act of giving in the health field has been largely neglected in philanthropic studies; the literal donation of self: blood, tissue, DNA, organs and bodies. There is a long tradition in bioethics research involving the ethical, legal and policy issues associated with donation, including factors involving the donation of bodies and their parts whether for transplantation, treatment, research, or education. This report describes the main outcomes of the Study Group, specifically the results of a national telephone survey conducted on our behalf by the IUPUI Public Opinion Lab; and the publications, scholarly presentations, and related outreach efforts in the media and elsewhere.
  • Thumbnail Image
    Item
    The need for xenotransplantation as a source of organs and cells for clinical transplantation
    (Elsevier, 2015-11) Ekser, Burcin; Cooper, David K. C.; Tector, A. Joseph; Department of Surgery, IU School of Medicine
    The limited availability of deceased human organs and cells for the purposes of clinical transplantation remains critical worldwide. Despite the increasing utilization of 'high-risk', 'marginal', or 'extended criteria' deceased donors, in the U.S. each day 30 patients either die or are removed from the waiting list because they become too sick to undergo organ transplantation. In certain other countries, where there is cultural resistance to deceased donation, e.g., Japan, the increased utilization of living donors, e.g., of a single kidney or partial liver, only very partially addresses the organ shortage. For transplants of tissues and cells, e.g., pancreatic islet transplantation for patients with diabetes, and corneal transplantation for patients with corneal blindness (whose numbers worldwide are potentially in the millions), allotransplantation will never prove a sufficient source. There is an urgent need for an alternative source of organs and cells. The pig could prove to be a satisfactory source, and clinical xenotransplantation using pig organs or cells, particularly with the advantages provided by genetic engineering to provide resistance to the human immune response, may resolve the organ shortage. The physiologic compatibilities and incompatibilities of the pig and the human are briefly reviewed.